Associate Professor, Internal Medicine, Washington University in St. Louis School of Medicine
Oncology
Dr. Cynthia X. Ma, MD
|
|
Give Review
Cynthia X. Ma, MD works in the field of Oncology. She researched medicine at Beijing Medical University. She received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Cynthia X. Ma is a published doctor and has 39 publications published. The lastest was: 'Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer.'
Publications
- A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast Cancer.
- Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience.
- Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast Cancer.
- US breast Cancer mortality trends in young women according to race.
- Body mass index, diabetes, and triple-negative breast Cancer prognosis.
- A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies.
- Incorporating genomics into breast Cancer clinical trials and care.
- Targeted therapy for breast Cancer.
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts.
- Psoriasis and dyslipidemia: a population-based study Analyzing the National Health and Nutrition Examination Survey (NHANES).
- Genetic polymorphism at Val(80) (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast Cancer.
- Combined Targeting of mTOR and AKT is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models.
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast Cancer.
- Diet and nutrition in psoriasis: Analysis of the National Health and Nutrition Examination Survey (NHANES) in the United States.
- Racial differences in outcomes of triple-negative breast Cancer.
- Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer.
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast Cancer.
- Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast Cancer.
- Neoadjuvant therapy in operable breast Cancer: application to triple negative breast Cancer.
- Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer.
- Imatinib mesylate-induced interstitial pneumonitis.
- Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple Myeloma.
- Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung Cancer.
- Human aromatase: gene resequencing and functional genomics.
- A comprehensive examination of CYP19 variation and risk of breast Cancer using two haplotype-tagging approaches.
- Neoadjuvant endocrine therapy for locally advanced breast Cancer.
- A comprehensive examination of CYP19 variation and Breast density.
- Predicting endocrine therapy responsiveness in breast Cancer.
- Neoadjuvant endocrine therapy for breast Cancer.
- A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
- Death by releasing the breaks: CHK1 inhibitors as Cancer therapeutics.
- Aromatase gene polymorphisms are associated with survival among patients with cardiovascular Disease in a sex-specific manner.
- Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast Cancer.
- Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors.
- Estrogen and progesterone receptors in breast Cancer.
- Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pa...
- Molecular profiling of triple negative breast Cancer.
- PARP inhibitors and their evolving role in breast Cancer.
Schools
Beijing College Of Traditional Chinese Medicine
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Mayo School of Graduate Medical Education -
Beijing Medical University
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1104842400 | |
| NPPES Provider LastName | MA | |
| NPPES Provider FirstName | CYNTHIA | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 657.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 88.0 | |
| Percent Opioid Claims | 13.39 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104842400 |
| Last Name Of The Provider | MA |
| First Name Of The Provider | CYNTHIA |
| View All |
Similar Doctors
|
|
Dr. Alexander E. Denes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack M. Lionberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy L. Bartlett, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. George Ansstas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy P. Rearden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron Bose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Westervelt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Benjamin R. Tan Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd A. Fehniger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Taneemul Haque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John S. Welch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Sorscher, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Camille Adeimy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald P. Linette, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Loren S. Michel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore S. Thomas, MD |